Stemprinter28 Aug 2020 10:15
Morning all
So I was doing some back of the fag-packet calculations last night for the potential value of Stemprinter and I just want to ask if my number are right...
1) According to the proactive interview from 22 May the only comparison we have is oncotype dx, which was purchased for $2.8 billion (£2.1b approx) and stemprinter is vastly superior.
2) Tils shareholers will each get 1 stemprinter share per Tiziana share held
3) Shares in issue on AIM = 190m (I am not sure how this works with a dual listing...does the 190m total shares figure include Nasdaq?)
so even if we base the valuation on oncotype dx, then I calculated stemprinter's share value as:
2,100,000,000 / 190,000,000 = £11 per share...
Can't help but feel that I made a mistake here somewhere...that figure seems massive! Can someone tell me if this rough guestimate is right or not?